The Journal of Psychopharmacology is an academic journal dedicated to the field of psychopharmacology, covering both basic and clinical research on psychotropic drugs. This magazine provides a platform for medical professionals to exchange the latest research findings and academic insights, including original research, reviews, case reports, as well as clinical and preclinical studies. The magazine pays special attention to the drug treatment of major mental illnesses, such as the efficacy and side effects of antipsychotics, mood stabilizers, and antidepressants, as well as exploring new drug targets and neural circuits.

The magazine encourages the use of biological markers, such as genetic markers, structural and functional imaging, neurocognitive function, etc., to evaluate drug efficacy. At the same time, attention is also paid to the research of individualized treatment plans, as well as drug research targeting inflammation and immunity, as these may play a certain role in the pathogenesis of mental illnesses. In addition, the magazine emphasizes the importance of precision medicine, especially in the fields of therapeutic drug monitoring and pharmacogenomics.

《精神药物杂志》是一个专注于精神药理学领域的学术期刊，涵盖了精神药物的基础与临床研究。该杂志为医学专业人员提供了一个交流最新研究成果和学术见解的平台，包括原创性研究、综述、病例报告以及临床和临床前研究等。杂志特别关注主要精神疾病的药物治疗，例如抗精神病药、心境稳定剂和抗抑郁剂的疗效和副反应，以及探索新的药物作用靶点和神经环路的研究 。

杂志鼓励使用生物学标记，如遗传标记、结构和功能影像、神经认知功能等，来评估药物疗效。同时，也关注个体化治疗方案的研究，以及针对炎症和免疫的药物研究，因为这些可能在精神疾病的发病机制中起到一定作用。此外，杂志还强调精准用药的重要性，尤其是在治疗药物监测和药物基因组学领域的应用 。

该刊已被国际权威数据库SCIE、SSCI收录，该刊致力于发表经过严格同行评审的高质量原创文章，反映Multiple领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2023年影响因子为2.1，平均审稿速度为 ，近四年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。